Date published: 2026-5-4

1-800-457-3801

SCBT Portrait Logo
Seach Input

NARFL Inhibitors

Chemical inhibitors of NARFL manipulate cellular pathways that are crucial for its function, particularly those involved in the assembly and maintenance of iron-sulfur clusters within the mitochondria. Cyclosporin A operates by inhibiting calcineurin, thereby indirectly affecting the cellular homeostasis and energy metabolism that NARFL requires to function efficiently. Oligomycin A exerts its inhibitory effect on mitochondrial ATP synthase, disrupting ATP production and thus the energy balance necessary for NARFL's role in biosynthetic pathways. Antimycin A and Rotenone target the mitochondrial electron transport chain, inhibiting complexes III and I, respectively. This diminishes the assembly of iron-sulfur clusters, which are vital for NARFL activity. Chloroquine disrupts iron homeostasis by altering endosomal pH, potentially hindering the iron-sulfur cluster assembly that NARFL facilitates.

Continuing with this theme, Deferoxamine chelates iron, directly impeding the availability of this essential metal for the iron-sulfur cluster assembly that NARFL is associated with. Zileuton's inhibition of 5-lipoxygenase alters leukotriene synthesis, which can indirectly modify the redox state within cells and thus affect the assembly of iron-sulfur clusters, leading to the inhibition of NARFL. Fenamiphos, an acetylcholinesterase inhibitor, may lead to oxidative stress, which in turn can impair the iron-sulfur cluster assembly machinery, thus inhibiting NARFL. The proteasome inhibitor Bortezomib disrupts protein homeostasis, which could lead to an indirect inhibition of NARFL by affecting its involvement in the iron-sulfur cluster assembly processes. Stattic, as a STAT3 inhibitor, changes gene expression profiles, potentially leading to a decrease in the cellular processes requiring NARFL. PD 98059 inhibits MEK in the MAPK pathway, potentially disrupting signaling pathways reliant on iron-sulfur cluster biogenesis, thus indirectly affecting NARFL. Lastly, Genistein, a tyrosine kinase inhibitor, could hinder signaling pathways that depend on the proper assembly of iron-sulfur clusters, which is necessary for the functional activity of NARFL in the cell.

SEE ALSO...

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 is an inhibitor of MEK, which is upstream of ERK in the MAPK pathway. Inhibition of this pathway can disrupt cellular signaling that requires iron-sulfur cluster biogenesis, thus indirectly inhibiting NARFL.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor. By inhibiting specific kinases, it could disrupt signaling pathways that rely on the iron-sulfur cluster assembly, which is necessary for NARFL's function.